[Clinical application of enzyme inhibitors for dementia].
Hirai
S
S
Department of Neurology, Gunma University, School of Medicine.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000109:Acetylcholine / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000242:Cyclic AMP / Q000378:metabolism; D003704:Dementia / Q000188:drug therapy*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D011480:Protease Inhibitors / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000494:pharmacology; D020889:Rolipram
D000806:Angiotensin-Converting Enzyme Inhibitors; D002800:Cholinesterase Inhibitors; D008996:Monoamine Oxidase Inhibitors; D011480:Protease Inhibitors; D011760:Pyrrolidinones; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D020889:Rolipram; D000109:Acetylcholine